Bâloise Holding (BALN) H1 2024 & Investor Update earnings summary
Event summary combining transcript, slides, and related documents.
H1 2024 & Investor Update earnings summary
20 Jan, 2026Executive summary
Shareholder profit rose 6.9% to CHF 220 million, driven by life business growth and strong contributions from Germany and Belgium, with diversified earnings across markets.
Refocusing strategy launched, ending non-core ecosystem activities to concentrate on core insurance and banking, technical profitability, and capital productivity.
Set new financial targets: ROE 12%-15%, combined ratio ~90%, life EBIT >CHF 200 million, and >CHF 2 billion cash remittance (2024–2027), with payout ratio of at least 80%.
Comprehensive equity rose 8.5% to CHF 7.8 billion; SST ratio stable at ~210%; S&P A+ rating confirmed.
Workforce reduction of 250 FTEs planned to improve cost efficiency.
Financial highlights
Group EBIT reached CHF 272 million; net income attributable to shareholders was CHF 220 million for HY 2024.
Non-life segment grew 4.6% in local currency; combined ratio at 90.4%; EBIT CHF 123 million, impacted by CHF 80 million in Swiss storm claims.
Life segment EBIT CHF 145 million, up 39% year-over-year; CSM increased from CHF 4.9 billion to CHF 5.3 billion; new business margin 5.7%.
Asset management and banking added CHF 700 million net new third-party assets; EBIT CHF 42 million.
Business volume CHF 5,293 million, down 0.9% year-over-year; adjusted for currency, up 0.3%.
Outlook and guidance
Targeting ROE 12%-15%, combined ratio ~90%, life EBIT >CHF 200 million, and >CHF 2 billion cash remittance (2024–2027).
Expense ratio in non-life to be reduced by 2-3 percentage points by 2027.
Cash remittance goal of >CHF 2 billion (2024–2027); payout ratio to shareholders of at least 80%, including share buybacks.
Share buybacks to be considered when cash for buybacks exceeds CHF 100 million.
Combined ratio outlook for FY 2024: 91-94%, reflecting claims and interest rate environment.
Latest events from Bâloise Holding
- Profit surged 60.6%, supporting a higher dividend and CHF 100 million share buyback.BALN
H2 202411 Feb 2026 - Profit up 25.5% to CHF 275.9m; combined ratio 90.6%; Helvetia merger on track for 2025.BALN
H1 202511 Feb 2026 - Merger creates Switzerland's largest insurer, with strong synergies and stable dividend outlook.BALN
Status Update10 Dec 2025 - Merger forms Switzerland's #2 insurer, targeting CHF 350m synergies and 20% dividend growth.BALN
M&A Announcement29 Nov 2025 - Refocusing strategy advances with strong cash remittance and resilient non-life growth.BALN
Q3 2024 TU13 Jun 2025